Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.11) by $0.14. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is -0.48%. On last trading day company shares ended up $4.18. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is … Continue reading Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

Morning Alert: Bally Technologies (NYSE:BYI), CSX. (NYSE:CSX), Snap-on Incorporated (NYSE:SNA), Arena Pharmaceuticals (NASDAQ:ARNA), Greenhill & Co. (NYSE:GHL)

Scientific Games Corp. agreed to acquire slot-machine maker Bally Technologies, Inc. (NYSE:BYI) for about $3.3 billion, furthering a consolidation of the gaming-equipment industry. Bally shareholders will get $83.30 a share, representing a 38% premium to the stock’s closing price on Thursday. Bally Technologies, Inc. (NYSE:BYI) belongs to Services sector. Its net profit margin is 10.90% and weekly performance is 24.80%. On last trading day company … Continue reading Morning Alert: Bally Technologies (NYSE:BYI), CSX. (NYSE:CSX), Snap-on Incorporated (NYSE:SNA), Arena Pharmaceuticals (NASDAQ:ARNA), Greenhill & Co. (NYSE:GHL)

SINA Corp (NASDAQ:SINA)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Thursday. They currently have a $52.00 target price on the stock. Zacks‘s target price suggests a potential upside of 4.75% from the stock’s previous close. SINA Corp (NASDAQ:SINA) stock performance was -0.38% in last session and finished the day at $48.45. Traded volume was … Continue reading Trader’s Recap – SINA (NASDAQ:SINA) , Arena Pharmaceuticals (NASDAQ:ARNA) , FelCor Lodging Trust (NYSE:FCH) , Anixter (NYSE:AXE) , Genomic (NASDAQ:GHDX)

Arena Pharmaceuticals, Inc.’s (NASDAQ:ARNA ) shares dropped 9.4% following news that its CEO Jack Lief, has sold around 40% of his stake in the company. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -5.29% in last session and finished the day at $5.01. Traded volume was 7.44million shares in the last session and the average volume of the stock remained 4.98million shares. The beta of the … Continue reading Healthcare Active Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Bristol-Myers Squibb (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), TherapeuticsMD (NYSEMKT:TXMD), Boston Scientific (NYSE:BSX)

Canadian Solar Inc. (NASDAQ:CSIQ) on July 7th, 2014 announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., on June 30th, completed the sale of the 10 MW AC solar photovoltaic (PV) power plant “Val Caron” valued at over CAD 60 million to One West Holdings Ltd., an affiliate of Concord Green Energy. Canadian Solar Inc. (NASDAQ:CSIQ) stock performance was -3.19% in last session and finished … Continue reading Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

CliniWorks today announced a strategic alliance between and Pfizer Inc. (NYSE:PFE) to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health. The two companies are partnering to develop a population health management platform solution that leverages CliniWorks’ technologies in disparate data aggregation and Natural Language Processing (which interprets free text … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Arena Pharmaceuticals (NASDAQ:ARNA), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)